The prevalence of BRCA1 and BRCA2 pathogenic variants in breast and other related cancers in various populations and clinical management guidelines of affected individuals were well established, and similar data of non-BRCA breast cancer susceptibility genes were also increasingly published. This evidence concerns the gene BRCA1 and breast carcinoma.